Sequence specificity, reactivity, and antitumor activity of DNA-alkylating pyrrole-imidazole diamides.
Sequence specificity, reactivity, and antitumor activity of DNA-alkylating pyrrole-imidazole diamides.
复制标题
DOI:
10.1016/s1074-5521(03)00160-1
复制
发表时间:
2003-08
影响因子:
--
通讯作者:
T. Bando;H. Iida;Z. Tao;A. Narita;N. Fukuda;T. Yamori;H. Sugiyama
中科院分区:
文献类型:
--
作者:
T. Bando;H. Iida;Z. Tao;A. Narita;N. Fukuda;T. Yamori;H. Sugiyama
Three conjugates of imidazole (Im)-pyrrole (Py) diamide and a DNA-alkylating moiety derived from the antibiotic duocarmycin A were synthesized, and their sequence specificity, reactivity, and antitumor activity comparatively examined. Sequencing gel analysis indicated that ImPyDu (1) alkylates DNA at the 3′ end of AT-rich sequences at micromolar concentration. ImPyDu86 (2) reacts with DNA at AT-rich sites together with dialkylation sites at micromolar concentration. ImPyLDu86 (3) efficiently alkylates dialkylation sites at nanomolar concentration. Average values of log IC50against a 39 cancer cell line panel of 1–3 were −4.59, −5.95, and −8.25, respectively. The differential growth inhibition pattern of 1–3 varied with relatively low correlation coefficients. Array-based gene expression monitoring was performed for 3 in a human lung cancer cell line. Substantial downregulation of expression was seen for genes involved in DNA damage response, transcription, and signal transduction.